CTRI/2024/05/067985尚未招募4 期
Anti hypertensive Efficacy Of Combination Therapy Of Sarpagandha Vati With Anuloman Chikitsa(Haritaki Churna) On Vyana Bala Vaishamya(Hypertension) randomised clinical trial - Nil
Ch Brahm Prakash Ayurved Charak Sansthan0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patient of either sex with age between 18-50 years.
- •Newly diagnosed stage1 primary hypertensive patients( not on medication)
排除标准
- •Primary hypertension other than stage1 eg. stage2, Benign hypertension, malignant hypertension, isolated hypertension.
- •Secondary hypertension.
- •Stage1, primary hypertension with co morbidities.
- •Stage1 hypertensive patient on regular medication.
- •Pregnant woman and lactating mother.
- •Gestational hypertension.
研究者
相似试验
已完成
Unknown
The effects of combined therapy for hypertension on arterial functiohypertension, type 2 diabetes mellitusJPRN-jRCT1091220034Masumi Ai, MD, PhDBioethics Research Center, Tokyo Medical and Dental University60
已完成
4 期
Combination of Antihypertensive therapy in the elderly, Multicenter Investigation <CAMUI> Multi-center randomized controlled study on efficacy of ARB/Diuretic mixture versus ARB/Ca channel blocker combination therapy to blood pressure or cognitive function in the elderly patients who have insufficient controlled hypertension in ARB monotherapyHypertensionJPRN-UMIN000001688Elderly Hypertension Conference200
已完成
4 期
Antihypertensive effect of combination therapy of telmisartan and low dose hydrochrolthiazide in hypertemnsive patientsJPRN-UMIN000000798on profit Organization LINE60
已完成
不适用
Evaluation for drug combination of antihypertensive agent and lipid-lowering agent in patients with hypertension and dyslipidemiaHypertension and dyslipidemiaJPRN-UMIN000008539Saitama Medical Center, Saitama Medical University30
已完成
4 期
Comparing anti-hypertensive combination therapy of fixed dose losartan and hydrochlorothiazide(HCTZ) versus angiotensin receptor blocker(ARB) and calcium channel blocker(CCB) on hypertensive patients whose blood pressures don't lower enough,effect and influence of metabolic system trial.HypertensionJPRN-UMIN000001692Hypertension and Metabolism Study group in East Saitama300